This inventor holds 11 USPTO granted patents and 2 published patent applications. Top assignees: Cardiovascular Biotherapeutics, Inc., Venturis Therapeutics, Inc., Trw Limited. Active years: 1985-2024.
Location History:
- Seattle, WA (US) (1985)
- King County, WA (US) (1985 - 1986)
- Amarillo, TX (US) (2015)
- Landover, MD (US) (2018)
- Berkeley, CA (US) (2018 - 2022)
Company Filing History:
4 out of 5 
3 out of 3 
1 out of 3,081 
Years Active: 1985-2024
Title: John W Jacobs: Innovator in Angiogenic Treatment
Introduction
John W Jacobs is a prominent inventor based in Berkeley, CA (US). He has made significant contributions to the field of medical technology, particularly in the area of angiogenic treatment. With a total of 11 patents to his name, Jacobs has focused on developing innovative solutions for ischemic tissue conditions.
Latest Patents
Among his latest patents, Jacobs has developed systems and methods for angiogenic treatment in wound healing. This invention relates to the diagnosis, amelioration, and treatment of ischemic tissues in patients suffering from diminished microvascular blood flow. His work categorizes patients into specific subsets that have the potential to respond to therapy. The invention includes various therapies that stimulate angiogenesis, vasculogenesis, arteriogenesis, and neovascularization to enhance tissue perfusion. Another notable patent involves therapeutic angiogenesis for the treatment of the spine and other tissues. This method addresses ischemic spinal conditions, degenerative disc disease, and back pain, categorizing patients based on their potential response to therapy.
Career Highlights
Throughout his career, Jacobs has worked with various companies, including Cardiovascular Biotherapeutics, Inc. His innovative approaches have positioned him as a leader in the field of medical inventions.
Collaborations
Jacobs has collaborated with notable individuals such as Vance Gardner and Thomas J Stegmann. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
John W Jacobs is a distinguished inventor whose work in angiogenic treatment has the potential to significantly improve patient outcomes in ischemic conditions. His innovative patents and collaborations reflect his commitment to advancing medical technology.